TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

ALFASIGMA

ImmunologyGastroenterologyInfectious Disease
Pharma

ALFASIGMA is a pharmaceutical company focused on Immunology, Gastroenterology, Infectious Disease.

2002
Since
1
Drugs
-
Trials
0
Approved (2yr)

Key Drugs

No active drugs

Recent Activity

No recent activity
SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Immunology 59%
0 drugs Phase 3: 4 Phase 2: 1 Phase 1: 1
Gastroenterology 31%
0 drugs Phase 3: 2 Phase 2: 1
Infectious Disease 6%
0 drugs Phase 2: 1
Oncology 3%
0 drugs Phase 1: 1

Pipeline Strength Pro

Loading...

Competitors Pro

Pfizer big-pharma
Oncology, Infectious Disease, Immunology, Gastroenterology
Bristol-Myers Squibb big-pharma
Oncology, Immunology, Gastroenterology, Infectious Disease
Merck big-pharma
Oncology, Infectious Disease, Immunology
AbbVie big-pharma
Immunology, Oncology, Infectious Disease
Gilead Sciences biotech
Infectious Disease, Oncology, Immunology, Gastroenterology